Results 61 to 70 of about 67,505 (283)

Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

open access: yesCureus
Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile pharmaceutical over the past 50 years.
Baneet Kaur, Cyril Blavo, Mayur Parmar
semanticscholar   +1 more source

A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?

open access: yesPLoS Neglected Tropical Diseases, 2021
Background Oral ivermectin is a safe broad spectrum anthelminthic used for treating several neglected tropical diseases (NTDs). Currently, ivermectin use is contraindicated in children weighing less than 15 kg, restricting access to this drug for the ...
P. Jittamala   +32 more
semanticscholar   +1 more source

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?

open access: yesInfectious Diseases of Poverty, 2019
Background There is accumulating evidence supporting the use of ivermectin as a malaria control tool. Recent findings from the repeat ivermectin mass drug administrations for control of malaria trial demonstrated a reduced incidence of malaria in ...
Joseph Nelson Siewe Fodjo   +5 more
doaj   +1 more source

Comparison between the efficacy of ivermectin and other drugs in treatment of cutaneous leishmaniasis [PDF]

open access: yesIraqi Journal of Veterinary Sciences, 2009
The study was conducted to compare the efficacy of ivermectin with some drugs in treatment of cutaneous leishmaniasis in vitro and in Balb/ C mice. The cultivation of Leishmania tropica was done on Nove MacNeal-Nicole medium (NNN).
M. A. Kadir, H. S. Aswad, A. M. Al-Samarai and G. A. Al-Mula
doaj   +1 more source

Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic

open access: yesSouth African Medical Journal, 2022
Background. Ivermectin is an antiparasitic drug that has shown in vitro activity against COVID‑19. Clinical studies supporting ivermectin for COVID‑19 prevention and treatment are conflicting, with important limitations. Public support for ivermectin is
V Pillay-Fuentes Lorente   +8 more
doaj   +1 more source

Strategies for the control of Rhipicephalus microplus ticks in a world of conventional acaricide and macrocyclic lactone resistance [PDF]

open access: yes, 2018
Infestations with the cattle tick, Rhipicephalus microplus, constitute the most important ectoparasite problem for cattle production in tropical and subtropical regions worldwide, resulting in major economic losses. The control of R.
Bhushan, Chandra   +2 more
core   +1 more source

A brief overview of current drug repurposing approaches for COVID-19 management [PDF]

open access: yes, 2020
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares   +1 more
core   +2 more sources

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

open access: yesJournal of Medical Virology, 2021
This trial compared the rate and time of viral clearance in subjects receiving a combination of nitazoxanide, ribavirin, and ivermectin plus Zinc versus those receiving supportive treatment.
H. Elalfy   +14 more
semanticscholar   +1 more source

Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin

open access: yesFrontiers in Molecular Neuroscience, 2012
Ivermectin is a gold standard anthelmintic drug that works by potently depressing neuronal activity and muscular contractility in arthropods and nematodes. At the molecular level, ivermectin activates inhibitory glutamate-gated chloride channels (GluClRs)
Timothy eLynagh, Joe eLynch
doaj   +1 more source

Caenorhabditis elegans muscle Cys-loop receptors as novel targets of terpenoids with potential anthelmintic activity [PDF]

open access: yes, 2019
The anthelmintic treatment of nematode infections remains the pillar of worm control in both human and veterinary medicine. Since control is threatened by the appearance of drug resistant nematodes, there is a need to develop novel compounds, among which
Bouzat, Cecilia Beatriz   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy